| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.0M | — | +106.2% |
| Cost of Revenue | $5.6M | — | +54.8% |
| Gross Profit | $465K | — | +169.6% |
| R&D Expense | $4.7M | — | +120.3% |
| SG&A Expense | $6.1M | — | +51.5% |
| Operating Income | -$10.3M | — | -51.3% |
| Pre-tax Income | -$10.3M | — | -49.6% |
| Net Income | -$10.3M | — | -49.6% |
| EPS (Basic) | -$0.74 | — | +42.2% |
| EPS (Diluted) | -$0.74 | — | +42.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.4M | -44.6% | -10.0% |
| Accounts Receivable | $5.3M | +146.7% | +162.4% |
| Inventory | $2.3M | +1.1% | +45.9% |
| Current Assets | $21.0M | -20.2% | +23.2% |
| Total Assets | $59.6M | +44.4% | +99.8% |
| Current Liabilities | $14.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.6M | — | -82.0% |
| Capital Expenditures | $111K | — | — |
| Investing Cash Flow | -$6.3M | — | -1307.1% |
| Financing Cash Flow | $8.8M | — | +6.0% |
| Free Cash Flow | -$11.7M | — | — |
| +85.9% |
| Long-term Debt | $4.0M | +0.5% | +1.6% |
| Total Liabilities | $25.6M | +89.5% | +119.6% |
| Stockholders' Equity | $34.0M | +22.5% | +87.2% |